California Hospitals Halt Gender-Affirming Care for Youth Amid Federal Pressure
CaliforniaS largest children’s hospital system and another major provider are no longer offering gender-affirming hormone therapy to individuals under 19, a move directly linked to escalating actions by the Trump administration aimed at restricting access to care for transgender youth. The decision impacts approximately 1,500 patients and reflects a broader trend of hospitals and clinics nationwide scaling back these vital services.
The shift at Rady Children’s Hospital in San Diego and a second unnamed facility has sent shockwaves thru families who rely on this care. one father, identified only as Brett, shared his experience with NPR, describing the profound positive impact hormone therapy had on his son after years of battling depression.”He just blossomed,” brett recounted, noting his son’s increased energy, friendships, and engagement in hobbies. “He came out of his shell even more” after beginning treatment.
However, that progress is now threatened.Brett learned just two weeks ago that Rady Children’s Health would discontinue gender-affirming hormone therapy, leaving him reeling. “The whole world kind of dropped out from under me,” he said. The hospital cited “escalating federal actions,” including a referral to the U.S. department of Health and Human Services Office of Inspector General for examination, as the reason for the change.
Over the past year, the Trump administration has pursued multiple avenues to limit access to gender-affirming care for minors, arguing that such treatments are harmful.These efforts include proposed rule changes from the Centers for Medicare and Medicaid Services that could cut federal funding to hospitals offering hormone therapy or surgery to transgender youth. According to the Movement Advancement Project, a think tank tracking LGBTQ policy, roughly 50% of hospital funding nationwide comes from federal programs like Medicare and Medicaid, making these proposed cuts especially impactful.
The Department of Health and Human Services stated that gender-affirming care does not meet “professionally recognized standards of health care,” a claim sharply contested by leading medical organizations. The American Academy of Pediatrics, the Endocrine Society, and the American Psychological Association all maintain that this care is evidence-based and essential for the mental health of transgender individuals. While the American Society of Plastic Surgeons recommends delaying gender-related surgeries until age 19, such surgeries are relatively rare among transgender minors.
The federal actions have already prompted more than a dozen hospitals across the country to end gender-affirming hormone therapy for youth. The situation is causing meaningful distress among both patients and providers. Alex Sheldon, executive director of the LGBTQ medical association GLMA, described hearing from healthcare workers facing unachievable ethical dilemmas. “That if their young person dies by suicide because they cannot get access to treatment, that it would be that nurse’s fault,” Sheldon relayed, recounting a statement made by a nurse to a concerned parent.
While private providers might potentially be able to absorb some of the demand, they lack the capacity of large hospital systems to serve a large patient base and conduct crucial research. Brett is currently searching for a private provider in San Diego County, but options are limited. “There’s only one in the county that we’ve been able to identify,” he said,adding that he’s unsure if that provider can even take his son as a patient. His family is even considering moving abroad to ensure continued access to care.
California Attorney General Rob Bonta has filed a lawsuit seeking a permanent injunction to restore care at Rady Hospital, but the immediate future
